Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on May 7, 2026 by admin

Oral small-molecule GLP-1 drugs penetrate deep into the brain to suppress cravings

NIH-funded research identifies new mechanism of action for next-generation weight-loss drugs
CategoriesUncategorized TagsAcademic research, Appetite and ingestive regulation, News Approved

Post navigation

Previous PostPrevious NIH-funded study suggests that testosterone suppresses brain tumor growth in males
Next PostNext Project Independence: Randomized Controlled Trial
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.